Living in Málaga? New cancer therapy trials could offer eligible patients another treatment option

Cancer patients living in Málaga may soon have an additional treatment option thanks to ongoing clinical trials of a new therapy called TIL. TIL therapy uses a patient's own immune cells to attack cancer cells. Hospital Regional Universitario de Málaga is conducting these trials for patients with advanced melanoma and non-small cell lung cancer through Andalucía’s public health system.

The trials involve obtaining tumour tissue from the patient, identifying immune cells called tumour-infiltrating lymphocytes (TILs), and multiplying these cells in a laboratory. The expanded population of TILs is then re-administered to the patient, with the aim of boosting their immune system's ability to fight cancer. This highly specialised process requires the expertise of multiple hospital departments and medical teams.

For residents of the Costa del Sol, these trials represent a potential new avenue for advanced cancer treatment. However, eligibility is not automatic and requires assessment by medical specialists. Factors considered include the type and progression of the tumour, previous treatments, availability of suitable tumour tissue, and the patient's overall health.

The initiative, led by the hospital's Medical Oncology Service in collaboration with researchers from IBIMA Plataforma Bionand, forms part of a broader cancer research program in Málaga.

International residents receiving healthcare through Andalucía’s public system should discuss TIL therapy with their medical team if they meet the criteria and are undergoing treatment for advanced melanoma or non-small cell lung cancer. While this development does not replace prevention, early diagnosis, or existing treatments, it provides an additional option for those eligible.

The trials underscore the advanced cancer research taking place within the same public health system that serves thousands of international residents on the Costa del Sol.